Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
  2. 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
  3. 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
  4. 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
  5. 4/A Derivatives Options or other derivatives
  6. 4/A Derivatives Options or other derivatives
  7. 4 Shares withheld for taxes Director gave up 1,475 shares (to pay taxes)
  8. 4 Shares withheld for taxes Director gave up 3,207 shares (to pay taxes)
  9. 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $33.20 ($67,529)
  10. 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $33.40 ($300,560)
  11. 4 Shares withheld for taxes Director gave up 901 shares (to pay taxes)
  12. 4 Planned sale EVP, CLO, Alkermes, Inc. sold 2,034 shares at $34.57 ($70,315)
  13. 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $35.51 ($319,604)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Planned sale VP, Finance (Interim PAO) sold 6,890 shares at $29.29 ($201,808)
  17. 4 Planned sale SVP, Chief Commercial Officer sold 6,000 shares at $30.00 ($180,000)
  18. 4 Derivatives Options or other derivatives
  19. 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $29.72 ($267,485)
  20. 4 Planned sale EVP, CLO, Alkermes, Inc. sold 4,068 shares at an average $29.53 ($120,108)

Page 2 of 67 · 1,323 filings